Buyse I, Sandkuyl L A, Zamani Ghabanbasani M, Gu X X, Bouillon R, Bex M, Dooms L, Emonds M P, Duhamel M, Marynen P
Center for Human Genetics, University of Leuven, Belgium.
Diabetologia. 1994 Aug;37(8):808-17. doi: 10.1007/BF00404338.
Using a highly discriminatory DNA typing technique, based on the polymerase chain reaction and reverse dot blot hybridization, more refined results were obtained on the association of particular HLA class II alleles, haplotypes and genotypes with insulin-dependent diabetes mellitus in the Belgian population. The previously reported predisposing effect for the DRB10301 encoded DR3 serologic specificity was confirmed and could be assigned to the DRB30200 encoded DR52b serologic specificity. A second high risk haplotype, DRB10401-DQB10302 encoding the DR4-DQ8 serologic specificity, accounted for increased susceptibility both in the total insulin-dependent diabetic population and among DR4-positive patients. Moreover, we found that these DR4 associated DRB1 and DQB1 alleles act as independent risk factors. A possible role for the DPB1 locus can be rejected since the observed predisposing effect for DPB10202 probably occurred due to linkage disequilibrium of this allele with DRB10301. Particular extended haplotypes accounted for the decreased relative risk observed for the DR2, DR11 and DR13 serologic specificities. The highest relative risk was observed for those DQA1/DQB1 genotypes, allowing for the formation of 4SS (DQ alpha Arg52+/DQ beta Asp57-) heterodimers.
采用基于聚合酶链反应和反向斑点杂交的高分辨率DNA分型技术,在比利时人群中就特定HLA II类等位基因、单倍型和基因型与胰岛素依赖型糖尿病的关联获得了更精确的结果。先前报道的由DRB10301编码的DR3血清学特异性的易患效应得到证实,且可归因于由DRB30200编码的DR52b血清学特异性。第二个高危单倍型,即编码DR4-DQ8血清学特异性的DRB10401-DQB10302,在总的胰岛素依赖型糖尿病患者群体以及DR4阳性患者中均导致易感性增加。此外,我们发现这些与DR4相关的DRB1和DQB1等位基因是独立的风险因素。DPB1位点的可能作用可以排除,因为观察到的DPB10202的易患效应可能是由于该等位基因与DRB10301的连锁不平衡所致。特定的扩展单倍型解释了观察到的DR2、DR11和DR13血清学特异性相对风险降低的原因。对于那些允许形成4SS(DQα精氨酸52+/DQβ天冬氨酸57-)异二聚体的DQA1/DQB1基因型,观察到了最高的相对风险。